Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five years ...
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.